Ashwini L Chand

13PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 12, 2025
Correction: Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.

Rhynelle S Dmello, Michelle Palmieri, Pathum S Thilakasiri

|Sep 17, 2024
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression.

Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe

|Apr 10, 2024
Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.

Rhynelle S Dmello, Michelle Palmieri, Pathum S Thilakasiri

|Nov 13, 2023
Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.

Pathum Thilakasiri, Ryan N O'Keefe, Sarah Q To

|Jun 22, 2022
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy.

Ashleigh R Poh, Christopher G Love, David Chisanga

|Jan 21, 2022
STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential.

Sarah Q To, Rhynelle S Dmello, Anna K Richards

Pageof 3